Predictions
Brookfield Corp.
Start price
Target price
Perf. (%)
€47.14
21.09.22
21.09.22
€58.00
21.09.23
21.09.23
-33.82%
22.09.23
22.09.23
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€77.18
21.09.22
21.09.22
€95.00
21.09.23
21.09.23
16.93%
22.09.23
22.09.23
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€77.18
21.09.22
21.09.22
€95.00
21.09.23
21.09.23
16.93%
22.09.23
22.09.23
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€77.18
21.09.22
21.09.22
€95.00
21.09.23
21.09.23
16.93%
22.09.23
22.09.23
Paypal Holdings Inc
Start price
Target price
Perf. (%)
€94.03
21.09.22
21.09.22
€110.00
21.09.23
21.09.23
-41.20%
22.09.23
22.09.23
Paypal Holdings Inc
Start price
Target price
Perf. (%)
€94.03
21.09.22
21.09.22
€110.00
21.09.23
21.09.23
-41.20%
22.09.23
22.09.23
Paypal Holdings Inc
Start price
Target price
Perf. (%)
€94.03
21.09.22
21.09.22
€110.00
21.09.23
21.09.23
-41.20%
22.09.23
22.09.23
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€0.78
21.09.22
21.09.22
€3.00
30.04.23
30.04.23
87.12%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year
Hugo Boss AG NA
Start price
Target price
Perf. (%)
€53.38
21.09.22
21.09.22
-
21.12.22
21.12.22
-11.75%
29.09.22
29.09.22
Business model of the past or high risk
Below average Marketposition
Little known brand
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€146.94
21.09.22
21.09.22
€120.00
21.09.23
21.09.23
-24.49%
19.12.22
19.12.22
Top 10 in its market
Revenue growth >5% per year expected
Good rating
Some uniques
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€146.94
21.09.22
21.09.22
€120.00
21.09.23
21.09.23
-24.49%
19.12.22
19.12.22
Top 10 in its market
Revenue growth >5% per year expected
Good rating
Some uniques
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€146.94
21.09.22
21.09.22
€120.00
21.09.23
21.09.23
-24.49%
19.12.22
19.12.22
Top 10 in its market
Revenue growth >5% per year expected
Good rating
Some uniques
flatexDEGIRO AG
Start price
Target price
Perf. (%)
€9.18
20.09.22
20.09.22
€6.00
20.09.23
20.09.23
0.33%
01.10.22
01.10.22
Could be worthwhile Investment >10% per year
Good culture
Below average Management
Little innovation
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Inovio Pharma
Start price
Target price
Perf. (%)
€1.88
20.09.22
20.09.22
€1.60
20.09.23
20.09.23
-7.46%
03.10.22
03.10.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€7.75
20.09.22
20.09.22
€3.00
20.09.23
20.09.23
-52.24%
11.01.23
11.01.23
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
Mercadolibre Inc
Start price
Target price
Perf. (%)
€910.20
20.09.22
20.09.22
€830.00
20.09.23
20.09.23
-6.83%
03.10.22
03.10.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Mercadolibre Inc
Start price
Target price
Perf. (%)
€910.20
20.09.22
20.09.22
€830.00
20.09.23
20.09.23
-6.83%
03.10.22
03.10.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
International Business Machines Corp
Start price
Target price
Perf. (%)
€125.86
20.09.22
20.09.22
€131.00
20.09.23
20.09.23
10.39%
31.10.22
31.10.22
Could be worthwhile Investment >10% per year
High dividend yield expected
Standard Investments for future growth
Future proof or reliable business model
International Business Machines Corp
Start price
Target price
Perf. (%)
€125.86
20.09.22
20.09.22
€131.00
20.09.23
20.09.23
10.39%
31.10.22
31.10.22
Could be worthwhile Investment >10% per year
High dividend yield expected
Standard Investments for future growth
Future proof or reliable business model
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.17
20.09.22
20.09.22
-
20.09.23
20.09.23
-15.38%
15.10.22
15.10.22
Risky Investment